drugset / Trial / NCT01442818

Patient Satisfaction and Pain Control Following Reconstructive Vaginal Surgery

NCT01442818

Completed 54 enrolled TriHealth Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The investigators hypothesize that patient controlled analgesia (PCA) provides superior pain relief and patient satisfaction when compared to scheduled intravenous analgesia following vaginal reconstructive surgery.

Timeline

Start
2010-09
Primary completion
2011-09
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydromorphone Other / unclassified 0.3 mg Intravenous
Subject Hydromorphone Other / unclassified 0.5 mg Intravenous

Indications

No indication recorded.